Artegraft, Inc. Release: 3-Year Prospective, Randomized Clinical Study at Massachusetts General Hospital Confirms Superiority of Artegraft to Cuffed Eptfe for Hemodialysis Access
Published: Jun 28, 2011
The study’s conclusion: The BCA graft is an excellent option for patients on hemodialysis that are not eligible for native arteriovenous fistulas, as these grafts required fewer interventions than the ePTFE grafts to maintain patency.
Artegraft vs Venaflo:
Overall Primary Patency Rate at 1 Year 60% vs10% Assisted Primary Patency Rate at 1 Year 60% vs 20% Assisted Primary Patency Rate at 2 Years 40% vs 14% Less Thrombosis, Fewer Interventions and No Pseudoaneurysms with BCA.